Amino Acid Polymorphisms in Hla Class II Differentiate Between Thyroid and Polyglandular Autoimmunity.
The structure of the human leucocyte antigen (HLA) peptide-binding clefts strongly contributes to monoglandular and polyglandular autoimmunity (AP). To investigate the impact of amino acid polymorphisms on the peptide binding interactions within HLA class II and its association with AP. immunogenetic study. Tertiary referral center for autoimmune endocrine diseases. 587 subjects with AP, autoimmune thyroid disease (AITD), type 1 diabetes (T1D) and healthy unrelated controls were typed for HLA class II. Amino acids within the peptide binding cleft that are encoded by HLA class II exon 2 were listed for all codon positions in all subjects. Overall comparisons between disease and control groups with respect to allele distribution at a given locus were performed by assembling rare alleles applying an exact Freeman Halton contingency table test with Monte-Carlo p values based on 150,000 samples. The Montecarlo Exact Fisher Test demonstrated marked differences in all three Loci, DQA1, DQB1, DRB1 (p<0.0001) between AP versus both AITD and controls, as well as between AP type II (Addison's disease as major endocrine component) and AP type III (T1D + AITD). Differences were also noted between AP and T1D pertaining to the DRB1 allele (p<0.041). The following seven amino acid positions DRB1-13, DRB1-26, DRB1-71, DRB1-74, DQA1-47, DQA1-56, and DQB1-57 significantly contributed to AP. Five positions in DQA1 (11, 47, 50, 56, and 69) completely correlated (p<0.0001). Amino acid polymorphisms within HLA class II exon 2 mediate the AP risk and differentiate between thyroid and polyglandular autoimmunity.